Sun 8 Nov 2026
All official websites of government entities in the Kingdom of Saudi Arabia end with.gov.sa.
Ensure the website is using the HTTPS protocol.
Registered with the Digital Government Authority under number:
| Scientific Name | Trade Name | Updated Section | Month |
|---|---|---|---|
| Canagliflozin | Invokana | 4.5. Interactions with other medicinal products | Oct,2022 |
| Ertugliflozin, Sitagliptin | Steglujan | 4.5. Interactions with other medicinal products | Oct,2022 |
| Topiramate | Topamax | 4.4. Special warnings and precautions for use | Oct,2022 |
| Dolutegravir, Lamivudine | Dovato | 4.8. Undesirable effects | Oct,2022 |
| Lansoprazole | Lanzor | 4.4. Special warnings and precautions for use | Oct,2022 |
| Dexlansoprazole | Dexilant | 4.4. Special warnings and precautions for use | Oct,2022 |
| Ritonavir,Nirmatrelvir | Paxlovid | 4.3 Contraindications 4.5 Interaction with other medicinal products | Oct ,2026 |
| Efanesoctocog alfa | Altuvoct | 4.8 Undesirable effects | Oct ,2026 |
| Valproic acid | Depakine | "4.8 Undesirable effects 4.6 Fertility, pregnancy and lactation" | Oct ,2026 |
| Vorasidenib | Voranigo | 4.8 Undesirable effects | Oct ,2026 |
Last update date: 02/11/2026 at 02:42 PM Saudi Arabia time
No feedback has been submitted for this page yet.
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.